Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM

(DSM)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Amsterdam
10/16/2019 10/17/2019 10/18/2019 10/21/2019 10/22/2019 Date
107.25(c) 109(c) 108.15(c) 107.45(c) 106.8(c) Last
637 273 689 193 459 481 473 529 525 090 Volume
-1.92% +1.63% -0.78% -0.65% -0.60% Change
More quotes
Financials (EUR)
Sales 2019 9 155 M
EBIT 2019 1 128 M
Net income 2019 806 M
Debt 2019 1 277 M
Yield 2019 2,26%
Sales 2020 9 642 M
EBIT 2020 1 233 M
Net income 2020 892 M
Debt 2020 1 208 M
Yield 2020 2,47%
P/E ratio 2019 22,7x
P/E ratio 2020 19,7x
EV / Sales2019 2,13x
EV / Sales2020 2,02x
Capitalization 18 256 M
More Financials
Company
Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals,... 
More about the company
Surperformance© ratings of Royal DSM
Trading Rating : Investor Rating :
More Ratings
Latest news on ROYAL DSM
10/22ROYAL DSM : DSM - repurchase of shares (14-18 October 2019)
PU
10/17ROYAL DSM : DSM to introduce bio- and/or recycled-based alternatives for its ent..
PU
10/15ROYAL DSM : DSM - repurchase of shares (7-11 October 2019)
PU
10/14ROYAL DSM : DSM puts a spotlight on better food, nutrition and health - inspired..
PU
10/08ROYAL DSM : DSM - repurchase of shares (30 September - 4 October 2019)
PU
08/08ROYAL DSM : Crossing thresholds
CO
08/07ROYAL DSM : Crossing thresholds
CO
08/05ROYAL DSM : Ex-dividend day for optional dividend
FA
08/01Evonik confirms 2019 outlook despite 'gloomy' economy, weaker second-quarter
RE
08/01ROYAL DSM : Crossing thresholds
CO
08/01ROYAL DSM : Slide show half-year results
CO
08/01ROYAL DSM : Half-year results
CO
07/25ROYAL DSM : DSM launches I AM Tomorrow Challenge to drive innovation in 3D print..
PU
07/19ROYAL DSM : DSM files for EU authorization of methane-reducing feed additive
PU
07/17ROYAL DSM : DSM will further upgrade its Vitamin C facility in Jiangshan, China ..
PU
More news
News in other languages on ROYAL DSM
09/23Des géants de l'agroalimentaire promettent de protéger la biodiversité
09/17EN DIRECT DES MARCHES : Airbus, Capgemini, Air France-KLM, Worldline, Vivendi..
09/17STOCK MARKET PARIS : Le pétrole, une nouvelle inconnue pour les marchés
09/16PRESSE : DSM erwägt Gebot für DuPont-Ernährungssparte
09/10AVIS D'ANALYSTES DU JOUR : BNP Paribas, LVMH, Pernod Ricard, Worldline, BigBen, ..
More news
Analyst Recommendations on ROYAL DSM
More recommendations
Sector news : Diversified Chemicals
10/22Rio Tinto smelter closure risk rocks New Zealand's top power supplier
RE
10/21BASF : Says Executive Board Member Sanjeev Gandhi to Leave, Reorganizes Board
DJ
10/17BASF, Partners to Consider Investing Up to $4 Billion in Indian Chemicals Sit..
DJ
10/15BASF : Consortium Invests in Crop Analytics Startup Hummingbird Technologies
DJ
10/10LAFARGEHOLCIM : Correction to LafargeHolcim Press Pickup
DJ
More sector news : Diversified Chemicals
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 114,87  €
Last Close Price 106,80  €
Spread / Highest target 37,6%
Spread / Average Target 7,56%
Spread / Lowest Target -35,4%
EPS Revisions
Managers
NameTitle
Feike Sijbesma Chairman-Management Board & CEO
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer
Pauline F. M. van der Meer Mohr Deputy Chairman
Victoria Franchetti Haynes Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM49.50%20 339
BASF SE11.32%69 183
DUPONT DE NEMOURS, INC.-11.81%49 157
SHIN-ETSU CHEMICAL CO., LTD.45.76%46 077
GROUPE BRUXELLES LAMBERT16.01%15 469
ASAHI KASEI CORPORATION6.68%14 899